This is the hallmark graduate fellowship award for PhD students in the U.S.

Eight PhD students in Georgia Tech’s School of Chemical and Biomolecular Engineering (ChBE) won 2020 National Science Foundation (NSF) Graduate Research Fellowships.

“This is the hallmark graduate fellowship award for PhD students in the U.S.,” says Professor Martha Grover, associate chair of graduate studies for ChBE.

NSF’s competitive Graduate Research Fellowship Program (GRFP) is the country’s oldest fellowship program that directly supports graduate students in various STEM (Science, Technology, Engineering and Mathematics) fields. Fellows benefit from a three-year annual stipend of $34,000 along with a $12,000 cost of education allowance for tuition and fees (paid to the institution) as well as opportunities for international research and professional development.

ChBE’s newest NSF Graduate Research Fellows are:

Elizabeth ChiltonElizabeth Chilton (Bioengineering), for the proposal “Engineered protein biosensor for low-resource cervical cancer screening”

 

 

 

Marlow DurbinMarlow Durbin (Chemical Engineering), for the proposal “Tailoring Mixed Conducting Interpenetrating Network Hydrogels for Bioelectronics”

 

 

 

Maria Rain JenningsMaria Rain Jennings (Chemical Engineering) for the proposal “Engineering a human enzyme to alleviate chronic, adenosine-mediated immunosuppression”

 

 

 

Kathryn LoefflerKathryn Loeffler (Chemical Engineering) for the proposal "Engineering Antigens for a Universal Fly Vaccine"

 

 

 

Nikki McArthurNikki McArthur (Chemical Engineering) for the proposal "Engineering Aggregate-Specific Polyvalent Antibodies”

 

 

 

Soham SinhaSoham Sinha (Senior Undergraduate, Bioengineering, attending Stanford University for PhD in fall) for the proposal, “Diagnosis and treatment of hearing loss in individuals in resource-poor settings through engineering an ultra-low-cost machine-learning enabled hearing aid platform”

 

 

Rebecca Schneider (Bioengineering) for the proposal, “Microfluidic hMSC-islet platform for the advancement of hMSC cell therapy for Type 1 Diabetes”

 

 

 

Bryan Wang – Bioengineering for the proposal “Metabolomics and secretomics enabled bioreactor design for human mesenchymal stromal cell manufacturing”